Taysha Gene Therapies Inc
Taysha Gene Therapies Inc (TSHA) Historical Volatility
TSHA 30-day historical volatility is 38%. This ranks in the 3th percentile of readings over the past year.
Read more
Tracking TSHA historical volatility helps you see how much Taysha Gene Therapies Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Taysha Gene Therapies Inc's HV tells you what really happened. Use our scanner to monitor TSHA 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The TSHA 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Taysha Gene Therapies Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments.
The company was incorporated in 2019 and is based in Dallas, Texas.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Taysha Gene Therapies Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where TSHA HV is running hot, cold, or in line. Make the TSHA 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 25, 2026
As of September 25, 2026
See how volatility has moved over time
Track TSHA historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→